Literature DB >> 21785836

Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells.

Na Wang1, Yan Wang, Guohua Yu, Chonggang Yuan, Jiyan Ma.   

Abstract

Parkinson's disease (PD) is an age-dependent neurodegenerative disorder characterized by dopaminergic neuron loss in substantia nigra. Previous studies have implicated a role of dopamine oxidation in PD. Dopamine oxidation leads to the formation of dopamine quinone, which generates reactive oxygen species and covalently modifies cysteinyl proteins to form quinoprotein adduct. We compared quinoprotein adduct formation and lipid peroxidation in different brain regions of young and old rats. We found a prominent age-dependent accumulation of quinoprotein adducts in the substantia nigra, while no significant change of lipid peroxidation was detected in any brain regions of 2- to 15-month old rats. To determine whether quinoprotein adduct formation correlates with dopamine-induced cytotoxicity, we analyzed dopamine treated SH-SY5Y cells and found a strong correlation between quinoprotein adduct formation and cytotoxicity. Together, our results indicate that quinoprotein adduct formation may play a role in the age-dependent selective vulnerability of dopaminergic neurons in PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785836     DOI: 10.1007/s11064-011-0541-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

Review 1.  Altered vesicular dopamine storage in Parkinson's disease: a premature demise.

Authors:  W Michael Caudle; Rebecca E Colebrooke; Piers C Emson; Gary W Miller
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

Review 2.  Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation.

Authors:  R E Zigmond; M A Schwarzschild; A R Rittenhouse
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

3.  Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.

Authors:  Ahmad Agil; Raquel Durán; Francisco Barrero; Blas Morales; Mariano Araúzo; Francisco Alba; Ma Teresa Miranda; Isabel Prieto; Manuel Ramírez; Francisco Vives
Journal:  J Neurol Sci       Date:  2005-10-10       Impact factor: 3.181

4.  Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. Multiple-site phosphorylation in vivo and in synaptosomes.

Authors:  J W Haycock; D A Haycock
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

5.  Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain.

Authors:  F H Khan; M Saha; S Chakrabarti
Journal:  Brain Res       Date:  2001-03-23       Impact factor: 3.252

6.  Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species.

Authors:  S B Berman; T G Hastings
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

7.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  Dopamine covalently modifies and functionally inactivates parkin.

Authors:  Matthew J LaVoie; Beth L Ostaszewski; Andreas Weihofen; Michael G Schlossmacher; Dennis J Selkoe
Journal:  Nat Med       Date:  2005-10-16       Impact factor: 53.440

9.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

10.  Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice.

Authors:  Linan Chen; Yunmin Ding; Barbara Cagniard; Amber D Van Laar; Amanda Mortimer; Wanhao Chi; Teresa G Hastings; Un Jung Kang; Xiaoxi Zhuang
Journal:  J Neurosci       Date:  2008-01-09       Impact factor: 6.167

View more
  9 in total

1.  Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.

Authors:  Hyo Jin Son; Ji Hyun Choi; Ji Ae Lee; Dong Jin Kim; Kye Jung Shin; Onyou Hwang
Journal:  J Mol Neurosci       Date:  2015-02-22       Impact factor: 3.444

2.  Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D.

Authors:  Andrew J Linsenbardt; Julie M Breckenridge; Gerald H Wilken; Heather Macarthur
Journal:  J Neurochem       Date:  2012-05-09       Impact factor: 5.372

Review 3.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

4.  Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.

Authors:  Jillienne C Touchette; Julie M Breckenridge; Gerald H Wilken; Heather Macarthur
Journal:  Neurosci Lett       Date:  2015-12-15       Impact factor: 3.046

5.  Zinc inhibits the reproductive toxicity of Zearalenone in immortalized murine ovarian granular KK-1 cells.

Authors:  Yijia Li; Xiaoyun He; Xuan Yang; Kunlun Huang; Yunbo Luo; Liye Zhu; Yuzhe Li; Wentao Xu
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

6.  Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease.

Authors:  Mária Baranyi; Pier Francesca Porceddu; Flóra Gölöncsér; Szabina Kulcsár; Lilla Otrokocsi; Ágnes Kittel; Annalisa Pinna; Lucia Frau; Paul B Huleatt; Mui-Ling Khoo; Christina L L Chai; Petra Dunkel; Peter Mátyus; Micaela Morelli; Beáta Sperlágh
Journal:  Mol Neurodegener       Date:  2016-01-13       Impact factor: 14.195

Review 7.  Redox Signaling in Neurotransmission and Cognition During Aging.

Authors:  Ashok Kumar; Brittney Yegla; Thomas C Foster
Journal:  Antioxid Redox Signal       Date:  2017-05-31       Impact factor: 8.401

8.  Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli.

Authors:  Guohua Yu; Liming Jiang; Yuanyuan Xu; Hongwei Guo; Huiyan Liu; Yi Zhang; Huaiyi Yang; Chonggang Yuan; Jiyan Ma
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

Review 9.  Efficacy of Sulforaphane in Neurodegenerative Diseases.

Authors:  Giovanni Schepici; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.